Inecalcitol, a vitamin D analog with less calcaemic potency, was shown to be eighteen times more effective as vitamin D in apoptosis induction in breast cancer cells, prompting growth halt even in VDR-deficient breast cancer cell lines resistant to vitamin D. VDR activation promotes apoptosis more easily in ER+ lines. Here, VDR is linked to breast carcinoma.